Furthermore, it has been recently demonstrated that patients with Behçet's disease have significantly lower memory B cell numbers in peripheral blood, particularly CD27+IgA+ B cells, when compared to controls, but treatment with adalimumab restored to normal levels blood B cell numbers [39]. The gene discussed is CD79A; the disease is Behcet disease.